WO2023220168A1 - Method and system of reducing limb ischemia - Google Patents

Method and system of reducing limb ischemia Download PDF

Info

Publication number
WO2023220168A1
WO2023220168A1 PCT/US2023/021722 US2023021722W WO2023220168A1 WO 2023220168 A1 WO2023220168 A1 WO 2023220168A1 US 2023021722 W US2023021722 W US 2023021722W WO 2023220168 A1 WO2023220168 A1 WO 2023220168A1
Authority
WO
WIPO (PCT)
Prior art keywords
radially expandable
tubular member
features
feature
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2023/021722
Other languages
English (en)
French (fr)
Inventor
Robert SWIERCZEK
Claudia Mourran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abiomed Inc
Original Assignee
Abiomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiomed Inc filed Critical Abiomed Inc
Priority to JP2024566340A priority Critical patent/JP2025517162A/ja
Priority to CN202380052141.5A priority patent/CN119497593A/zh
Priority to AU2023269047A priority patent/AU2023269047A1/en
Priority to CA3252885A priority patent/CA3252885A1/en
Priority to EP23804207.1A priority patent/EP4522036A4/en
Publication of WO2023220168A1 publication Critical patent/WO2023220168A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027—Type of occlusion
    • A61B17/12036—Type of occlusion partial occlusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1011—Multiple balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136—Balloons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3655—Arterio-venous shunts or fistulae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3659—Cannulae pertaining to extracorporeal circulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3666—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1002—Balloon catheters characterised by balloon shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/12127—Double occlusion, e.g. for creating blood-free anastomosis site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M2025/0001—Catheters; Hollow probes for pressure measurement
    • A61M2025/0002—Catheters; Hollow probes for pressure measurement with a pressure sensor at the distal end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1047—Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1097—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1018—Balloon inflating or inflation-control devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1027—Making of balloon catheters
    • A61M25/1034—Joining of shaft and balloon

Definitions

  • the present disclosure relates to methods, devices, and systems used in the prevention of limb ischemia, such as that resulting from use of a mechanical circulatory support device.
  • Limb ischemia is a rapid and sudden decrease in limb perfusion often threatening limb viability. It may occur as a result of blockage of blood due to an indwelling sheath and/or catheter, local occlusion (e.g., atherosclerotic narrowing), and/or continuous occlusion resulting from small vessels and/or large sheaths. It may also occur as a result of a closure issue.
  • local occlusion e.g., atherosclerotic narrowing
  • continuous occlusion resulting from small vessels and/or large sheaths. It may also occur as a result of a closure issue.
  • Limb ischemia is associated with mortality, and some literature indicates the rate of limb ischemia may be high. As such, in addition to negatively impacting the patient, it may also negatively impact ongoing clinical trials.
  • a device may be provided.
  • the device may include a tubular member.
  • the device may include one or more radially expandable features disposed on an outer surface of the tubular member.
  • the one or more radially expandable features may be configured to be selectively expanded from a collapsed configuration to an expanded configuration to allow blood within a blood vessel of a patient to flow from a point upstream of the one or more radially expandable features, around and/or through the one or more radially expandable features, and to a point downstream of the one or more radially expandable features.
  • the one or more radially expandable features may include one or more balloons.
  • the one or more radially expandable features may extend along a portion of a length of the tubular member.
  • Each radially expandable feature may have an identical axial length. In some embodiments, at least one of the one or more radially expandable features may have a different axial length than another of the one or more radially expandable features.
  • the one or more radially expandable features may include a plurality of radially expandable features. Each radially expandable feature may be separated circumferentially from an adjacent radially expandable feature by an identical distance. In some embodiments, each of the plurality of radially expandable features may be separated circumferentially from an adjacent radially expandable feature. A circumferential separation distance of a first adjacent pair of adjacent radially expandable features may be different from a circumferential separation distance of a second adjacent paid of adjacent radially expandable features.
  • a central axis of each radially expandable features may be parallel to a central axis of the tubular member. At least one radially expandable feature may be disposed in a helical pattern on the outer surface of the tubular member. At least one radially expandable feature may have an oval or circular cross-sectional shape. At least one radially expandable feature may have a polygonal cross-sectional shape.
  • Each of the radially expandable feature(s) may be fluidly connected to a fluid source.
  • Each of the radially expandable feature(s) may be operably connected to a connector.
  • the radially expandable feature(s) may include a hydrostatic skeleton.
  • a device may be provided.
  • the device may include a tubular member and may include a hydrostatic skeleton coupled to the tubular member.
  • the hydrostatic skeleton may be configured to be selectively inflated (“expanded”) or deflated (“compressed”).
  • the hydrostatic skeleton may be configured to be expanded from a collapsed configuration to an expanded configuration to create at least a first channel for allowing blood to flow from a point upstream of the hydrostatic skeleton, through the first channel, to a point downstream of the hydrostatic skeleton.
  • the hydrostatic skeleton may be configured to be selectively inflated or deflated to create at least the first channel and a second channel.
  • the cross-sectional area of the first channel and a cross-sectional area of the second channel may be identical.
  • the cross-sectional area of the first channel and a cross-sectional area of the second channel may be different.
  • a cross-sectional area of the first channel may be controlled separately from the cross-sectional area of the second channel.
  • the tubular member may be configured to slidably receive a second tubular member.
  • the device may include a valve at a proximal end of the tubular member, the valve being operably coupled to the second channel.
  • the hydrostatic skeleton may extend fully around a circumference of the tubular member.
  • the hydrostatic skeleton may extend only partially around a circumference of the tubular member.
  • the hydrostatic skeleton may be coupled to a distal end of the tubular member. At least a portion of the hydrostatic skeleton may extend along an axial length of the tubular member. A diameter of the first channel may increases when the hydrostatic skeleton is inflated.
  • the hydrostatic skeleton may include a plurality of annular rings.
  • a method may be provided.
  • the method may include positioning a tubular member within a blood vessel, the tubular member having an outer surface and at least one radially expandable member coupled to the outer surface.
  • the method may include expanding the least one radially expandable feature from a collapsed configuration to an expanded configuration to allow blood to flow from a point upstream of the at least one radially expandable feature, around and/or through (e.g., through an opening or channel created by the feature) the at least one radially expandable feature, and to a point downstream of the at least one radially expandable feature.
  • the step of expanding the at least one radially expandable feature may include expanding a portion of the blood vessel around the at least one radially expandable feature.
  • the step of expanding from a collapsed configuration to an expanded configuration may include expanding all of the plurality of radially expandable features simultaneously.
  • the step of expanding from a collapsed configuration to an expanded configuration may include selectively expanding fewer than all of the plurality of radially expandable features.
  • the step of expanding from a collapsed configuration to an expanded configuration may occur automatically based on received information.
  • the received information may be a determination that an ischemic event is occurring, or may be occurring.
  • the received information may be a value from a sensor.
  • the method may include measuring a pressure within the blood vessel, such as upstream and/or downstream from the from the radially expandable feature(s).
  • the at least one radially expandable feature may include a balloon.
  • the at least one radially expandable feature may include a hydrostatic skeleton.
  • Figure 1 A is an illustration of a device positioned within a blood vessel.
  • Figure IB illustrates a cross-section of the device of Figure 1.
  • Figure 1C illustrates a cross-section of another embodiment of a device according to the present disclosure.
  • Figure 2A is an illustration of a device positioned within a blood vessel.
  • Figure 2B-2C are illustrations of various embodiments of cross-sections of the device of Figure 2 A.
  • Figure 2D is an illustration of another embodiment of a device position within a blood vessel.
  • Figures 2E-2F are illustration of various embodiments of cross-sections of the device of Figure 2D.
  • Figure 2G is an illustration of another embodiment of a device position within a blood vessel.
  • Figure 3 is a flowchart of a method.
  • limb ischemia is a rapid and sudden decrease in a patient’s limb perfusion, which may occur because of a blockage of blood due to an indwelling sheath and/or catheter, a local occlusion (e.g., an atherosclerotic narrowing), and/or a continuous occlusion resulting for small vessels and/or large sheaths.
  • Limb ischemia also may occur as a result as a result of a closure device.
  • a small diameter catheter may be inserted distally to provide antegrade flow to the ischemic limb.
  • the catheter may be inserted either in the dorsalis pedis artery, or the posterior tibial.
  • the antegrade flow may be introduced at any suitable time (e.g., at the time of initial ECMO cannulation or implantation of a mechanical circulatory support device or at a later time, such as after an ischemia is discovered).
  • conventional solutions may not be available to all patients. For example, some patients may not have a large enough dorsalis pedis artery or posterior tibial for a catheter to be introduced.
  • the inventors have recognized that improved patient outcomes may result when ischemic events are quickly identified and addressed.
  • the inventors have also recognized the benefit of promoting and providing distal limb perfusion to patients whose arteries are occluded by expanding the vasculature around at least a portion of a fully introduced cannula (e.g., introducer sheath).
  • expanding the vasculature around at least a portion of the cannula may allow for blood flow (e.g., retrograde flow) to go around and past the cannula.
  • the disclosed devices and methods may address the unmet needs of currently existing distal limb perfusion techniques.
  • the disclosed devices and methods also may reduce the number of insertion sites in a patient, which may reduce the risk of infection, sepsis, bleeding, hematoma, ischemia, and pseudoaneurysm.
  • the device 100 may include a tubular member 110, which may be inserted into the patient’s vasculature.
  • the tubular member may be designed to be inserted at an access point 20, through skin 22, and into a blood vessel 10, as shown in FIG. 1A.
  • the tubular member may be a sheath, a cannula, and/or a catheter, although other suitable tubular members may be used.
  • the tubular member may be composed of any appropriate material, such as nitinol, a medical grade polymer (such as a polyurethane), and/or combinations thereof.
  • the tubular member may be formed of other suitable materials in other embodiments
  • the tubular member may be configured to selectively expand the at least a portion of the patient’s vasculature around the tubular member.
  • the tubular member may include one or more features 120 configured to expand radially, to move at least a portion 12 of the vessel 10 away from the tubular member to allow blood to flow 140 from a point 141 upstream of the feature(s), between the tubular member and the vessel, and to a point 142 dow nstream of the feature(s).
  • the features may have a collapsed configuration, such as when the tubular member is inserted into the patient, and an expanded configuration, such as that shown in FIG.
  • a diameter e.g., a distance from the center of the tubular member to the outer most portion of the expandable feature
  • a diameter of the tubular member in larger when the features are in the expanded configuration than when the features are in the collapsed configuration.
  • the feature may be composed of any appropriate material, such as nitinol, a medical grade polymer (such as a polyurethane), or other suitable materials.
  • the feature may be formed of an expandable material.
  • the features may each include a balloon that may be inflatable, such as via the controlled addition of a fluid from a fluid source 132.
  • the device may include a controller 130 that selectively expands and/or contracts the features by adding and/or removing the fluid from the feature.
  • the fluid may be saline, although other suitable Aids, such as gas, may be used.
  • the fluid may pass through one or more lumens (not shown) in the tubular member.
  • the fluid source may be fluidly coupled to the features via the one of more lumens in the tubular member.
  • the tubular member may include a plurality of features 120 extending around a circumference of the tubular member.
  • the features may be configured such that each feature 120 may be disposed on an outer surface 112 of the tubular member 110.
  • An inner surface 114 of the tubular member may define a lumen 116 extending therethrough.
  • the number of features may vary. As seen in FIG. IB, the device may have three features. In FIG. 1C, the device is shown as having five features. However, any number of features may be present.
  • the tubular member may have one or more expandable features.
  • the arrangement of the radially expandable feature(s) may vary.
  • the one or more radially expandable features may extend along a portion of an axial length 122 of the tubular member.
  • each radially expandable feature may have an identical axial length.
  • the radially expandable features may not be identical.
  • at least one radially expandable feature may have a different axial length than another.
  • at least one radially expandable feature may have a diameter that is different than that of another radially expandable feature.
  • a central axis of each radially expandable features may be parallel to a central axis of the tubular member.
  • the radially expandable feature(s) may be disposed in a helical pattern (or partial helical pattern) on the outer surface of the tubular member.
  • radially expanding features may be separated along an axial length of the tubular member, not just simply circumferentially separated from one another.
  • the device may include a plurality of radially expandable features.
  • the features may be arranged in various ways relative to each other.
  • each radially expandable features may be separated circumferentially from an adjacent radially expandable feature by an identical distance.
  • a circumferential separation distance of an adjacent pair of the plurality of adjacent radially expandable features is different from a circumferential separation distance of a different adjacent pair of the plurality' of adjacent radially expandable features.
  • the shape of the radially expandable features may vary.
  • the radially expandable feature(s) may have an oval or circular cross-sectional shape, a polygonal cross-sectional shape, or a combination thereof.
  • Each feature may have an identical cross-sectional shape.
  • at least one feature has a different cross-sectional shape compared to another feature.
  • the features may be attached to the tubular member in any suitable fashion.
  • the features may be glued, bonded, or otherwise affixed thereto.
  • the features may not be removable from the tubular member.
  • the features also may be integrally formed with the tubular member in some embodiments.
  • the feature may be configured to be attachable to the tubular member (e.g., by a clinician) before insertion of the tubular member into the patient's vasculature.
  • the radially expanding feature may be configured as a hydrostatic skeleton, as shown in FIGS. 2A-2C.
  • the device 200 may include a tubular member 110 having a hydrostatic skeleton 220 coupled to the tubular member.
  • the hydrostatic skeleton may be attached in a manner similar to that of the features described herein.
  • the hydrostatic skeleton may be comprised of any appropriate flexible material, such a polyurethane or Teflon, which can be inflated to a certain pressure that corresponds to a particular outer diameter.
  • the hydrostatic skeleton may be connected to a fluid source and a controller which may selectively add and/or remove fluid from the skeleton to selectively expand the hydrostatic skeleton to allow blood flow around the tubular member.
  • the hydrostatic skeleton may have a collapsed and expanded configuration.
  • the hydrostatic skeleton may be configured to be selectively inflated or deflated to create at least a first channel 222 (see FIG. 2B and FIG. 2E) for allowing blood to flow 140 from a point 141 upstream of the hydrostatic skeleton, through the first channel, and to a point 142 dow nstream of the hydrostatic skeleton.
  • expansion of the hydrostatic skeleton also may increase a diameter of the patient’s vasculature around the expanded skeleton.
  • the maximum diameter (such as a maximum effective diameter) of the first channel may be IFr, 3Fr, 5Fr, 7Fr, 9 Fr, 10 Fr, 11 Fr, 12 Fr, 13 Fr, 15 Fr, 17 Fr, 20 Fr, or 23 Fr.
  • the hydrostatic skeleton may be configured to be selectively inflated or deflated to create at least a first channel 222, and optionally a second channel 223 (see FIGS. 2C and 2F).
  • the maximum diameter (such as a maximum effective diameter) of the second channel may be IFr, 3Fr, 5Fr, 7 Fr, 9 Fr, 10 Fr, 11 Fr, 12 Fr, 13 Fr, 15 Fr, 17 Fr, 20 Fr, or 23 Fr.
  • the first and/or second channels may have any suitable diameters.
  • the hydrostatic skeleton may be formed with other suitable numbers of channels.
  • the effective diameter of the first and second channels may be the same, although the diameters also may vary.
  • the first and/or second channels may have any suitable shape.
  • the hydrostatic skeleton When initially deployed and in the collapsed configuration, the hydrostatic skeleton will have a minimal cross-section. When inflated and in the expanded configuration, the hydrostatic skeleton may have a cross-sectional area that is no greater than a cross-sectional area of the tubular member. In some embodiments, the hy drostatic skeleton may have a cross- sectional area that relatively smaller than a cross-sectional area of the tubular member. Referring to FIG. 2B, a relatively small hydrostatic skeleton is shown with a single channel (e.g., only first channel 222). In other embodiments, the hydrostatic skeleton may have a diameter that is the same as that of the tubular member. In still other embodiments, as illustrated in FIGS.
  • the hydrostatic skeleton may have a cross-sectional area that larger than that of the tubular member.
  • a hydrostatic skeleton is shown with a relatively larger cross-sectional area relative to the tubular member.
  • the outer surface 112 of the tubular member 110 may form a portion of the first channel 222.
  • the skeleton may include plurality of channels, including, e.g., first channel 222 and second channel 223.
  • the skeleton may include a separator 225 such that at least two channels can be controlled separately.
  • the separator may include a membrane separating the first and second channels.
  • the separator may be a portion of the skeleton and may itself be expandable.
  • a cross- sectional area of the first and second channels may be identical. In some embodiments, a cross- sectional area of the first and second channels may be different.
  • a diameter of the first channel may increases as the hydrostatic skeleton is inflated.
  • a cross-sectional area of the first channel may be controlled separately from the cross-sectional area of the second channel.
  • the membrane or divider 225 may fluidly separate the portion of the skeleton around first channel 222 from the portion around second channel 223, thus allow each section to be controlled separately.
  • the device simply has two separate hydrostatic skeletons, each with a single channel.
  • the tubular member 200 may be configured to slidably receive an additional tubular member 230 (such as a catheter). This may be received, e.g., through a channel or lumen 202 (see e.g., FIG. 2A).
  • the maximum diameter (such as a maximum effective diameter) of the channel or lumen 202 may be 9 Fr, 10 Fr, 11 Fr, 12 Fr, 13 Fr, 15 Fr, 17 Fr, 20 Fr, or 23 Fr.
  • the device may include a valve 212 at a proximal end 118 of the tubular member 110.
  • the valve may be operably coupled to channel or lumen 202.
  • the valve may be configured to receive an additional tubular member 230.
  • the tubular member 110 and the additional tubular member 230 may be integrally formed.
  • the hydrostatic skeleton may be coupled at or near the distal end of the tubular member. In some embodiments, the hydrostatic skeleton may extend fully around a circumference of the tubular member. In some embodiments, the hydrostatic skeleton may extend only partially around a circumference of the tubular member.
  • the hydrostatic skeleton 220 may extend along an axial length 122 of the tubular member.
  • the hydrostatic skeleton 220 may include a plurality of axially separated rings 240, where each ring may be in contact with the tubular member 110.
  • each ring may be controlled individually (e.g., selectively expanded via the fluid).
  • the entire skeleton is controlled as a collective unit.
  • two or more rings may be separated by a connector 241, which may allow fluid to pass from one ring to a connected ring.
  • the connector also may maintain a prescribed distance between adjacent rings.
  • the rings may form a single channel extending through the hydrostatic skeleton (see, e.g., FIG. 2E).
  • one or more rings may define two channels.
  • the channels may be configured for passage of other devices.
  • the hydrostatic skeleton may be configured to allow an additional tubular member 250 to extend at least partially through the hydrostatic skeleton.
  • the tubular member 250 may extend through the entire hydrostatic skeleton.
  • the additional tubular member may extend through one or more rings 240 of the hydrostatic skeleton.
  • the tubular member 250 may extend through only one of the channels of the hydrostatic skeleton.
  • the devices used herein may be used to reduce and/or prevent limb ischemia, as described in the method provided herein.
  • the method 300 may include positioning 310 a tubular member within a blood vessel.
  • the tubular member may allow passage of one or more medical devices, such as a mechanical circulatory support device used to treat the patient.
  • the tubular member may reduce and/or prevent the flow of blood through the blood vessel in at least one portion of the blood vessel, which may cause ischemia.
  • the method may therefore also include expanding 320 at least one radially expandable feature from a collapsed configuration to an expanded configuration to expand the portion of the blood vessel and allow blood to flow from a point upstream of the at least one radially expandable feature, around or through the at least one radially expandable feature, and to a point downstream of the at least one radially expandable feature
  • the expandable feature may include a hydrostatic skeleton
  • the method may include allowing blood to flow through one or more channels of an expanded hydrostatic skeleton.
  • expanding from a collapsed configuration to an expanded configuration may include expanding 322 all of the plurality of radially expandable features simultaneously. Expanding from a collapsed configuration to an expanded configuration may also include selectively expanding 324 fewer than all of the plurality of radially expandable features.
  • expanding the at least one radially expandable feature may include inflating the at lest one expandable feature by providing a fluid to the expandable feature from a fluid source.
  • expanding from a collapsed configuration to an expanded configuration may include receiving 326 information, and then, based on the received information, automatically e 328 from a collapsed configuration to an expanded configuration.
  • the disclosed device may include one or more sensors 102 (such as one or more pressure sensors positioned along the device, within the blood vessel).
  • the method may include automatically expanding the features from the collapsed configuration to the expanded configuration.
  • one or more processors may determine that, based on values from the one or more sensors (or from another device, such as a monitoring patch or a mechanical circulatory support device), that an ischemic event is occurnng, or may be occurring, and based on that determination, automatically expanding the one or more features from the collapsed configuration to the expanded configuration.
  • the method may include gathering the necessary data to allow such automatic corrections to occur, such as measuring 330 a pressure within the blood vessel, such as upstream and/or downstream from the from the radially expandable feature(s).
  • the method may include removing the tubular member from the patient.
  • the method may thereafter include deflating 340 the at least one expandable feature such that the at least one feature returns to the collapsed state.
  • This step may also include ensuring that all of the radially expandable features are in a collapsed configuration.
  • the method may finally include removing 350 the tubular member from the blood vessel and closing the access site.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • External Artificial Organs (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
PCT/US2023/021722 2022-05-10 2023-05-10 Method and system of reducing limb ischemia Ceased WO2023220168A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2024566340A JP2025517162A (ja) 2022-05-10 2023-05-10 四肢虚血を軽減する方法及びシステム
CN202380052141.5A CN119497593A (zh) 2022-05-10 2023-05-10 减少肢体缺血的方法和系统
AU2023269047A AU2023269047A1 (en) 2022-05-10 2023-05-10 Method and system of reducing limb ischemia
CA3252885A CA3252885A1 (en) 2022-05-10 2023-05-10 METHOD AND SYSTEM FOR REDUCING LIMB ISCHEMIA
EP23804207.1A EP4522036A4 (en) 2022-05-10 2023-05-10 METHOD AND SYSTEM FOR REDUCING LIMB ISCHEMIA

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263340358P 2022-05-10 2022-05-10
US63/340,358 2022-05-10

Publications (1)

Publication Number Publication Date
WO2023220168A1 true WO2023220168A1 (en) 2023-11-16

Family

ID=88699979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/021722 Ceased WO2023220168A1 (en) 2022-05-10 2023-05-10 Method and system of reducing limb ischemia

Country Status (8)

Country Link
US (1) US20230363761A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522036A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025517162A (cg-RX-API-DMAC7.html)
CN (1) CN119497593A (cg-RX-API-DMAC7.html)
AU (1) AU2023269047A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252885A1 (cg-RX-API-DMAC7.html)
TW (1) TW202408427A (cg-RX-API-DMAC7.html)
WO (1) WO2023220168A1 (cg-RX-API-DMAC7.html)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581017A (en) * 1983-03-07 1986-04-08 Harvinder Sahota Catheter systems
US5000734A (en) * 1988-02-01 1991-03-19 Georges Boussignac Probe intended to be introduced within a living body
US5554119A (en) * 1991-08-02 1996-09-10 Scimed Drug delivery catheter with manifold
US20050096691A1 (en) * 2003-10-29 2005-05-05 Medtronic Vascular, Inc. Distal protection device for filtering and occlusion
US20110224606A1 (en) * 2010-03-10 2011-09-15 Shibaji Shome Method and apparatus for remote ischemic conditioning during revascularization
US20140324092A1 (en) * 2008-06-02 2014-10-30 Loma Vista Medical, Inc. Inflatable medical devices

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395333A (en) * 1993-09-01 1995-03-07 Scimed Life Systems, Inc. Multi-lobed support balloon catheter with perfusion
US5501667A (en) * 1994-03-15 1996-03-26 Cordis Corporation Perfusion balloon and method of use and manufacture
US6117064A (en) * 1997-01-06 2000-09-12 Apple; Marc G. Catheter system
US6695864B2 (en) * 1997-12-15 2004-02-24 Cardeon Corporation Method and apparatus for cerebral embolic protection
US6776771B2 (en) * 2000-09-14 2004-08-17 Tuborg Engineering Adaptive balloon with improved flexibility
US9308086B2 (en) * 2010-09-21 2016-04-12 Hocor Cardiovascular Technologies Llc Method and system for balloon counterpulsation during aortic valve replacement
US20090264820A1 (en) * 2008-04-16 2009-10-22 Abiomed, Inc. Method and apparatus for implanting an endoluminal prosthesis such as a prosthetic valve
CN102858272B (zh) * 2009-12-15 2015-07-15 爱德华兹生命科学公司 治疗脉管通道的膨胀设备
US20120209375A1 (en) * 2011-02-11 2012-08-16 Gilbert Madrid Stability device for use with percutaneous delivery systems
US10799348B2 (en) * 2012-10-18 2020-10-13 Loma Vista Medical, Inc. Reinforced inflatable medical devices
WO2014080425A2 (en) * 2012-11-22 2014-05-30 Anand Gnanaraj The perfusion & filter balloon
US10646227B2 (en) * 2016-12-29 2020-05-12 Cerepeutics, LLC Systems and methods for acute treatment to limit intracerebral hemorrhage growth
JP7361205B2 (ja) * 2019-08-23 2023-10-13 シー・アール・バード・インコーポレーテッド 使用中の血流を可能にする弁形成医療デバイス

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581017A (en) * 1983-03-07 1986-04-08 Harvinder Sahota Catheter systems
US4581017B1 (en) * 1983-03-07 1994-05-17 Bard Inc C R Catheter systems
US5000734A (en) * 1988-02-01 1991-03-19 Georges Boussignac Probe intended to be introduced within a living body
US5554119A (en) * 1991-08-02 1996-09-10 Scimed Drug delivery catheter with manifold
US20050096691A1 (en) * 2003-10-29 2005-05-05 Medtronic Vascular, Inc. Distal protection device for filtering and occlusion
US20140324092A1 (en) * 2008-06-02 2014-10-30 Loma Vista Medical, Inc. Inflatable medical devices
US20110224606A1 (en) * 2010-03-10 2011-09-15 Shibaji Shome Method and apparatus for remote ischemic conditioning during revascularization

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP4522036A4 *

Also Published As

Publication number Publication date
CA3252885A1 (en) 2023-11-16
AU2023269047A1 (en) 2024-11-28
EP4522036A1 (en) 2025-03-19
TW202408427A (zh) 2024-03-01
US20230363761A1 (en) 2023-11-16
EP4522036A4 (en) 2026-06-03
CN119497593A (zh) 2025-02-21
JP2025517162A (ja) 2025-06-03

Similar Documents

Publication Publication Date Title
US12053600B2 (en) Introducer set
CN113040865B (zh) 血管内导管
EP1694398B1 (en) Expandable percutaneous sheath
US8057503B2 (en) Blood vessel occluder and method of use
US6143015A (en) Device and method for partially occluding blood vessels using flow-through balloon
CA2341481C (en) Perfusion-isolation catheter apparatus and method
US9393041B2 (en) Expandable medical access sheath
EP1427460B1 (en) Catheter having radially expandable main body
US8888740B2 (en) Partial aortic occlusion devices and methods for cerebral perfusion augmentation
US20050124937A1 (en) Expandable percutaneous sheath
US20100286722A1 (en) Temporary venous filter system
EP4032490A1 (en) Anchoring and non-occluding intravascular device for use during clot removal via aspiration and/or mechanical extraction device
EP3932340B1 (en) Isolated stenting with distal balloon
US20230363761A1 (en) Method and system of reducing limb ischemia
WO2023220100A1 (en) Method and system for reducing limb ischemia
JP2007252895A (ja) 血管内異物除去用カテーテル
JP2025145386A (ja) カテーテルデバイス及び回収対象物の回収方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23804207

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2024566340

Country of ref document: JP

Ref document number: AU2023269047

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2023269047

Country of ref document: AU

Date of ref document: 20230510

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2023804207

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2023804207

Country of ref document: EP

Effective date: 20241210

WWE Wipo information: entry into national phase

Ref document number: 202380052141.5

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 202380052141.5

Country of ref document: CN